Permanently Discontinued

PMS-SUMATRIPTAN

PHARMASCIENCE INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is PMS-SUMATRIPTAN discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that PMS-SUMATRIPTAN 50MG has been permanently discontinued (last updated November 16, 2021). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is PMS-SUMATRIPTAN not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength50MG

Report last updated2021-11-16

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

TEVA-SUMATRIPTAN DF

TEVA CANADA LIMITED

50MG · DIN 02286823

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

PRO-SUMATRIPTAN

PRO DOC LIMITEE

50MG · DIN 02324652

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

JAMP SUMATRIPTAN DF

JAMP PHARMA CORPORATION

50MG · DIN 02545306

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

IMITREX DF - TAB 100MG

GLAXOSMITHKLINE INC

100MG · DIN 02212161

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

MYLAN-SUMATRIPTAN

MYLAN PHARMACEUTICALS ULC

25MG · DIN 02268906

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

TEVA-SUMATRIPTAN

TEVA CANADA LIMITED

100MG · DIN 02239367

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

PMS-SUMATRIPTAN

PMS-SUMATRIPTAN: may not contain the correct amount of tablets (empty blister packs)

Type II2025-08-29

Moderate health risk

Possible match — not confirmed

DIN

02256436

Strength

50MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

SUMATRIPTAN

See all SUMATRIPTAN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2021-11-16

Permanently Discontinued

Business reasons

Other Products from PHARMASCIENCE INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

AC&C TABLETS

DIN 02303299

ACET CODEINE 30

DIN 01999648

ACET CODEINE 60

DIN 01999656

ACETAMINOPHEN, CAFFEINE & CODEINE

DIN 02025337

ACETAMINOPHEN, CAFFEINE & CODEINE

DIN 02028174

ARTHRITIS PAIN RELIEF

650MG · DIN 02527901